Cogent Biosciences, Inc. (COGT)

34.88 +0.31 (+0.90%) USD  |  NASDAQ  |  Sep 03, 15:41
More

Cogent Biosciences Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2020 --
December 31, 2019 --
December 31, 2018 --
Date Value
December 31, 2017 --
December 31, 2016 --
December 31, 2015 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Apogee Therapeutics, Inc. --
Erasca, Inc. --
Moderna, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --